The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Assessment of Racial Disparities in Biomarkers for Alzheimer Disease
Open accessAbstract
Importance: Racial differences in molecular biomarkers for Alzheimer disease may suggest race-dependent biological mechanisms. Objective: To ascertain whether there are racial disparities in molecular biomarkers for Alzheimer disease. Design, Setting, and Participants: A total of 1255 participants (173 African Americans) were enrolled from January 1, 2004, through December 31, 2015, in longitudinal studies at the Knight Alzheimer Disease Research Center at Washington University and completed a magnetic resonance imaging study of the brain and/or positron emission tomography of the brain with Pittsburgh compound B (radioligand for aggregated amyloid-β) and/or cerebrospinal fluid (CSF) assays for the concentrations of amyloid-β42, total tau, and phosphorylated tau181. Independent cross-sectional analyses were conducted from April 22, 2016, to August 27, 2018, for each biomarker modality with an analysis of variance or analysis of covariance including age, sex, educational level, race, apolipoprotein E (APOE) ε4 allele status, and clinical status (normal cognition or dementia). All biomarker assessments were conducted without knowledge of the clinical status of the participants. Main Outcomes and Measures: The primary outcomes were hippocampal volumes adjusted for differences in intracranial volumes, global cerebral amyloid burden as transformed into standardized uptake value ratios (partial volume corrected), and CSF concentrations of amyloid-β42, total tau, and phosphorylated tau181. Results: Of the 1255 participants (707 women and 548 men; mean [SD] age, 70.8 [9.9] years), 116 of 173 African American participants (67.1%) and 724 of 1082 non-Hispanic white participants (66.9%) had normal cognition. There were no racial differences in the frequency of cerebral ischemic lesions noted on results of brain magnetic resonance imaging, mean cortical standardized uptake value ratios for Pittsburgh compound B, or for amyloid-β42 concentrations in CSF. However, in individuals with a reported family history of dementia, mean (SE) total hippocampal volumes were lower for African American participants than for white participants (6418.26 [138.97] vs 6990.50 [44.10] mm3). Mean (SE) CSF concentrations of total tau were lower in African American participants than in white participants (293.65 [34.61] vs 443.28 [18.20] pg/mL; P < .001), as were mean (SE) concentrations of phosphorylated tau181 (53.18 [4.91] vs 70.73 [2.46] pg/mL; P < .001). There was a significant race by APOE ε4 interaction for both CSF total tau and phosphorylated tau181 such that only APOE ε4-positive participants showed the racial differences. Conclusions and Relevance: The results of this study suggest that analyses of molecular biomarkers of Alzheimer disease should adjust for race. The lower CSF concentrations of total tau and phosphorylated tau181 in African American individuals appear to reflect a significant race by APOE ε4 interaction, suggesting a differential effect of this Alzheimer risk variant in African American individuals compared with white individuals.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Desikan, R. S., Ségonne, F., Fischl, B., Quinn, B. T., Dickerson, B. C., Blacker, D., Buckner, R. L., Dale, A. M., Maguire, R. P., Hyman, B. T., et al. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.01.021 · Cited by 13,324
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
Jack, C. R., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., et al. (2018) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2018.02.018 · Cited by 10,537
Self-citationThe Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Self-citationFischl, B. (2012) · NeuroImage · doi:10.1016/j.neuroimage.2012.01.021 · Cited by 9,526
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
Buckner, R. L., Head, D., Parker, J., Fotenos, A. F., Marcus, D., Morris, J. C., & Snyder, A. Z. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.06.018 · Cited by 1,296
Self-citationInverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ 42 in humans
Fagan, A. M., Mintun, M. A., Mach, R. H., Lee, S., Dence, C. S., Shah, A. R., LaRossa, G. N., Spinner, M. L., Klunk, W. E., Mathis, C. A., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20730 · Cited by 1,246
Self-citationApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy
Initiative, A. D. N., Shi, Y., Yamada, K., Liddelow, S. A., Smith, S. T., Zhao, L., Luo, W., Tsai, R. M., Spina, S., Grinberg, L. T., et al. (2017) · Nature · doi:10.1038/nature24016 · Cited by 1,220
Self-citationTrial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease
Honig, L. S., Vellas, B., Woodward, M., Boada, M., Bullock, R., Borrie, M., Hager, K., Andreasen, N., Scarpini, E., Liu-Seifert, H., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1705971 · Cited by 1,049
Morris, J. C., Weintraub, S., Chui, H. C., Cummings, J., DeCarli, C., Ferris, S., Foster, N. L., Galasko, D., Graff-Radford, N., Peskind, E. R., et al. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000213865.09806.92 · Cited by 950
Self-citationCorrection for partial volume effects in PET: principle and validation.
ROUSSET, O. G., Ma, Y., & Evans, A. C. (1998) · PubMed · Cited by 919
The Alzheimer's Disease Centers' Uniform Data Set (UDS): The Neuropsychologic Test Battery
Weintraub, S., Salmon, D., Mercaldo, N., Ferris, S., Graff-Radford, N. R., Chui, H., Cummings, J., DeCarli, C., Foster, N. L., Galasko, D., et al. (2009) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318191c7dd · Cited by 888
Self-citationInequalities in dementia incidence between six racial and ethnic groups over 14 years
Mayeda, E. R., Glymour, M. M., Quesenberry, C. P., & Whitmer, R. A. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2015.12.007 · Cited by 883
Incidence of AD in African-Americans, Caribbean Hispanics, and Caucasians in northern Manhattan
Tang, M.-X., Cross, P., Andrews, H., Jacobs, D. M., Small, S., Bell, K., Merchant, C., Lantigua, R., Costa, R., Stern, Y., et al. (2001) · Neurology · doi:10.1212/wnl.56.1.49 · Cited by 722
(2006) · Annals of Neurology · doi:10.1002/(issn)1531-8249 · Cited by 513
Dickerson, B. C., Goncharova, I., Sullivan, M. P., Forchetti, C., Wilson, R. S., Bennett, D. A., Beckett, L. A., & deToledo-Morrell, L. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00271-8 · Cited by 482
Incidence and Prevalence of Dementia in the Cardiovascular Health Study
Fitzpatrick, A. L., Kuller, L. H., Ives, D. G., Lopez, O. L., Jagust, W., Breitner, J. C. S., Jones, B., Lyketsos, C., & Dulberg, C. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52058.x · Cited by 438
Reitz, C., Jun, G., Naj, A., Rajbhandary, R., Vardarajan, B. N., Wang, L.-S., Valladares, O., Lin, C.-F., Larson, E. B., Graff-Radford, N. R., et al. (2013) · JAMA · doi:10.1001/jama.2013.2973 · Cited by 431
Risk of Dementia Among White and African American Relatives of Patients With Alzheimer Disease
Green, R. C. (2002) · JAMA · doi:10.1001/jama.287.3.329 · Cited by 391
Yaffe, K., Falvey, C., Harris, T. B., Newman, A., Satterfield, S., Koster, A., Ayonayon, H., Simonsick, E., & Study, F. T. H. A. (2013) · BMJ · doi:10.1136/bmj.f7051 · Cited by 363
Alzheimer’s Disease In African Americans: Risk Factors And Challenges For The Future
Barnes, L. L., & Bennett, D. A. (2014) · Health Affairs · doi:10.1377/hlthaff.2013.1353 · Cited by 353
Literacy and Memory Decline Among Ethnically Diverse Elders
Manly, J. J., Touradji, P., Tang, M.-X., & Stern, Y. (2003) · Journal of Clinical and Experimental Neuropsychology · doi:10.1076/jcen.25.5.680.14579 · Cited by 329
Brain Morphology in Older African Americans, Caribbean Hispanics, and Whites From Northern Manhattan
Brickman, A. M., Schupf, N., Manly, J. J., Luchsinger, J. A., Andrews, H., Tang, M. X., Reitz, C., Small, S. A., Mayeux, R., DeCarli, C., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.8.1053 · Cited by 268
Quantitative Analysis of PiB-PET with FreeSurfer ROIs
Su, Y., D'Angelo, G. M., Vlassenko, A. G., Zhou, G., Snyder, A. Z., Marcus, D. S., Blazey, T. M., Christensen, J. J., Vora, S., Morris, J. C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073377 · Cited by 246
Self-citationApolipoprotein E and alzheimer's disease: Ethnic variation in genotypic risks
Maestre, G., Ottman, R., Stern, Y., Gurland, B., Chun, M., Tang, M., Shelanski, M., Tycko, B., & Mayeux, R. (1995) · Annals of Neurology · doi:10.1002/ana.410370217 · Cited by 243
Howell, J. C., Watts, K. D., Parker, M. W., Wu, J., Kollhoff, A., Wingo, T. S., Dorbin, C. D., Qiu, D., & Hu, W. T. (2017) · Alzheimer's Research & Therapy · doi:10.1186/s13195-017-0315-1 · Cited by 198
Severe Dementia: Prevalence and Clinical Features in a Biracial US Population
Schoenberg, B. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04210090004002 · Cited by 185
The ARIC-PET amyloid imaging study: Brain amyloid differences by age, race, sex, and APOE
Gottesman, R. F., Schneider, A. L. C., Zhou, Y., Chen, X., Green, E., Gupta, N., Knopman, D. S., Mintz, A., Rahmim, A., Sharrett, A. R., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002914 · Cited by 172
The Prevalence and 3-Year Incidence of Dementia in Older Black and White Community Residents
Fillenbaum, G. G., Heyman, A., Huber, M. S., Woodbury, M. A., Leiss, J., Schmader, K. E., Bohannon, A., & Trapp-Moen, B. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00024-9 · Cited by 164
Lack of an association between apolipoprotein E ϵ4 and Alzheimer's disease in elderly nigerians
Osuntokun, B. O., Sahota, A., Ogunniyi, A. O., Gureje, O., Baiyewu, O., Adeyinka, A., Oluwole, S. O., Komolafe, O., Hall, K. S., Unverzagt, F. W., et al. (1995) · Annals of Neurology · doi:10.1002/ana.410380319 · Cited by 159
TREM2 is associated with increased risk for Alzheimer’s disease in African Americans
Jin, S. C., Carrasquillo, M. M., Benitez, B. A., Skorupa, T., Carrell, D., Patel, D., Lincoln, S., Krishnan, S., Kachadoorian, M., Reitz, C., et al. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0016-9 · Cited by 153
Self-citationTwo rare AKAP9 variants are associated with Alzheimer's disease in African Americans
Logue, M. W., Schu, M., Vardarajan, B. N., Farrell, J., Bennett, D. A., Buxbaum, J. D., Byrd, G. S., Ertekin‐Taner, N., Evans, D., Foroud, T., et al. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.06.010 · Cited by 136
Cruchaga, C., Kauwe, J. S. K., Mayo, K., Spiegel, N., Bertelsen, S., Nowotny, P., Shah, A. R., Abraham, R., Hollingworth, P., Harold, D., et al. (2010) · PLoS Genetics · doi:10.1371/journal.pgen.1001101 · Cited by 128
Self-citationUtilizing the Centiloid scale in cross-sectional and longitudinal PiB PET studies
Su, Y., Flores, S., Hornbeck, R. C., Speidel, B., Vlassenko, A. G., Gordon, B. A., Koeppe, R. A., Klunk, W. E., Xiong, C., Morris, J. C., et al. (2018) · NeuroImage: Clinical · doi:10.1016/j.nicl.2018.04.022 · Cited by 126
Self-citationFarrer, L. A. (1997) · JAMA · doi:10.1001/jama.1997.03550160069041 · Cited by 124
Szanton, S. L., Rifkind, J. M., Mohanty, J. G., Miller, E. R., Thorpe, R. J., Nagababu, E., Epel, E. S., Zonderman, A. B., & Evans, M. K. (2011) · International Journal of Behavioral Medicine · doi:10.1007/s12529-011-9188-z · Cited by 110
Gordon, B. A., Blazey, T., Su, Y., Fagan, A. M., Holtzman, D. M., Morris, J. C., & Benzinger, T. L. S. (2016) · JAMA Neurology · doi:10.1001/jamaneurol.2016.2642 · Cited by 105
Self-citationTwo novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans
Mez, J., Chung, J., Jun, G., Kriegel, J., Bourlas, A. P., Sherva, R., Logue, M. W., Barnes, L. L., Bennett, D. A., Buxbaum, J. D., et al. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.09.002 · Cited by 105
Neuropathologic differences by race from the National Alzheimer's Coordinating Center
Graff‐Radford, N. R., Besser, L. M., Crook, J. E., Kukull, W. A., & Dickson, D. W. (2016) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2016.03.004 · Cited by 102
Brain Behavior Relationships Among African Americans, Whites, and Hispanics
DeCarli, C. S., Reed, B., Jagust, W. J., Martinez, O., Ortega, M., & Mungas, D. (2008) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318185e7fe · Cited by 91
Upward drift in cerebrospinal fluid amyloid β 42 assay values for more than 10 years
Schindler, S. E., Sutphen, C. L., Teunissen, C. E., McCue, L. M., Morris, J. C., Holtzman, D. M., Mulder, S. D., Scheltens, P., Xiong, C., & Fagan, A. M. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.06.2264 · Cited by 51
Self-citationBeta-amyloid and Cortical Thickness Reveal Racial Disparities in Preclinical Alzheimer's Disease
McDonough, I. M. (2017) · NeuroImage Clinical · doi:10.1016/j.nicl.2017.09.014 · Cited by 51
Enrichment of clinical trials in MCI due to AD using markers of amyloid and neurodegeneration
Wolz, R., Schwarz, A. J., Gray, K. R., Yu, P., Hill, D., & Initiative, A. D. N. (2016) · Neurology · doi:10.1212/wnl.0000000000003126 · Cited by 47
Type 2 Diabetes and Ethnic Disparities in Cognitive Impairment
Noble, J. M., Manly, J. J., Schupf, N., Tang, M., & Luchsinger, J. A. (2012) · PubMed · doi:10.13016/gt2j-7why · Cited by 45
The Neuropathology of Alzheimer Disease in African American and White Individuals
Wilkins, C. H., Grant, E., Schmitt, S. E., McKeel, D. W., & Morris, J. C. (2006) · Archives of Neurology · doi:10.1001/archneur.63.1.87 · Cited by 45
Self-citationThe Prevalence of Alzheimer Neuropathologic Lesions Is Similar in Blacks and Whites
Riudavets, M. A., Rubio, A. I., Cox, C., Rudow, G. L., Fowler, D. R., & Troncoso, J. C. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000248548.20799.a3 · Cited by 38
Racial/ethnic variation of APOE alleles for lobar intracerebral hemorrhage
Sawyer, R. P., Sekar, P., Osborne, J., Kittner, S. J., Moomaw, C. J., Flaherty, M. L., Langefeld, C. D., Anderson, C. D., Rosand, J. M., & Woo, D. (2018) · Neurology · doi:10.1212/wnl.0000000000005908 · Cited by 32
Ethics Reporting in Publications About Research With Alzheimer's Disease Patients
Stocking, C. B., Hougham, G. W., Baron, A. R., & Sachs, G. A. (2004) · Journal of the American Geriatrics Society · doi:10.1111/jgs.2004.52.issue-2 · Cited by 18
Cited by
Blood-based biomarkers for Alzheimer's disease: towards clinical implementation
Teunissen, C. E., Verberk, I. M. W., Thijssen, E. H., Vermunt, L., Hansson, O., Zetterberg, H., van der Flier, W. M., Mielke, M. M., & del Campo, M. (2022) · The Lancet Neurology · doi:10.1016/s1474-4422(21)00361-6 · Cited by 1,045
(2019) · Handbook of Clinical Neurology · doi:10.1016/b978-0-12-804766-8.00013-3 · Cited by 783
The probabilistic model of Alzheimer disease: the amyloid hypothesis revised
Frisoni, G. B., Altomare, D., Thal, D. R., Ribaldi, F., van der Kant, R., Ossenkoppele, R., Blennow, K., Cummings, J., van Duijn, C., Nilsson, P. M., et al. (2022) · Nature Reviews Neuroscience · doi:10.1038/s41583-021-00533-w · Cited by 513
Brickman, A. M., Manly, J. J., Honig, L. S., Sanchez, D., Reyes‐Dumeyer, D., Lantigua, R. A., Lao, P. J., Stern, Y., Vonsattel, J. P., Teich, A. F., et al. (2021) · Alzheimer's & Dementia · doi:10.1002/alz.12301 · Cited by 387
Gut microbiome composition may be an indicator of preclinical Alzheimer’s disease
Ferreiro, A. L., Choi, J., Ryou, J., Newcomer, E. P., Thompson, R., Bollinger, R. M., Hall-Moore, C., Ndao, I. M., Sax, L., Benzinger, T. L. S., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.abo2984 · Cited by 356
Self-citation
Metadata
- Authors
- Morris, J. C., Schindler, S. E., McCue, L. M., Moulder, K. L., Benzinger, T. L. S., Cruchaga, C., Fagan, A. M., Grant, E., Gordon, B. A., Holtzman, D. M., & Xiong, C.
- Venue
- JAMA Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2019-03-01
- Volume
- 76
- Issue
- 3
- Pages
- 264
- ISSN
- 2168-6149 (ISSN-L)
- OpenAlex
- W2906702113
- Cited by
- 370
- References
- 49
- FWCI
- 29.70
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.